Page 8 - Cough Syrup

Cough syrup case: Manufacturing activities stopped at Noida pharma firm

All manufacturing activities at Marion Biotech's Noida unit have been stopped in view of reports of contamination of its cough syrup Dok-1 Max, Union Health Minister Mansukh Mandaviya said on Friday. Further investigation in connection with the death of 18 children in Uzbekistan allegedly linked to the cough syrup is going on, he said in a tweet. "Following inspection by @CDSCO_INDIA_INF team in view of reports of contamination in cough syrup Dok1 Max, all manufacturing activities of Marion Biotech at NOIDA unit have been stopped yesterday night, while further investigation is ongoing," Mandaviya said. The company's legal representative had said on Thursday that the manufacture of Dok-1 Max has stopped "for now". Mandaviya had said Thursday that further action would be taken based on the inspection of the pharma company. Marion Biotech does not sell Dok-1 Max in India and its only export has been to Uzbekistan, an Uttar Pradesh government official had said. Samples of the cough s

Cough syrup deaths: Centre, UP team inspect pharma firm's Noida unit

Cough syrup maker linked to Uzbekistan deaths halts production; samples of Dok-1 Max sent for analysis

India starts probe after Uzbekistan cough syrup deaths, Noida firm responds

According to the ministry, chemical ethylene glycol was found in a batch of syrup during laboratory tests

Top Headlines: India's billionaire club shrinks, Airtel 5G monetisation

Business Standard brings you the top headlines at this hour

After Gambia, now Uzbekistan alleges Indian cold drug killed its children

Noida-based Marion Biotech's Dok-1 Max anti-cold medicine under scanner after the Central Asian nation blames it for 18 deaths

Patchy recovery: How 2022 swung from despair to hope to caution

Even as it grappled with new viruses, the human race hit another milestone

Maiden Pharma cough syrup row: Gambian Parliament seeks legal action

WHO, however, said samples tested in Ghana and Switzerland were found to be contaminated

Gambia panel seeks Indian manufacturer's prosecution for cough syrup deaths

A parliamentary committee in The Gambia has recommended prosecution of an Indian manufacturer of cough syrups suspected of causing the deaths of at least 70 children in the West African country

Maiden Pharma seeks to reopen Sonipat plant after DCGI clearance

Health ministry sources say no immediate plan to allow plant to re-open, it was closed for non-compliance with GMP, not for contamination issues

WHO stands by action of issuing alert against Maiden Pharma cough syrup

Asserts that testing done in labs in Ghana and Switzerland confirmed excess levels of contaminated syrups that are "dangerous and should not be in any medicine, ever"

Maiden Pharma's cough syrups are safe, WHO jumped the gun: DCGI

'Irreparable damage' to Indian pharma's global image, drug regulator writes to WHO

Flu season starts, but demand for cough-cold meds remains weak

Impact in US among the worst in the past 10 years

Role of Maiden Pharma cough syrups in Gambia kids' deaths not confirmed

Indian Health ministry sources say the Haryana-based drug maker is currently being probed for lapses in good manufacturing practices

Cough syrup deaths in the Gambia serious issue, says WHO chief scientist

Swaminathan was speaking to reporters on Thursday on the sidelines of the annual general meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN) here

Cough syrup deaths in Gambia serious issue, says WHO chief scientist

Chief scientist at the World Health Organization (WHO) Dr Soumya Swaminathan on Thursday said the death of children in Gambia, potentially linked to four Indian-made cough syrups, was a serious issue. Swaminathan was speaking to reporters on the sidelines of the annual general meeting of the Developing Countries Vaccine Manufacturers Network (DCVMN) here. A WHO report has linked the death of 66 children in Gambia to four Indian-made cough syrups. "Certainly, the government is in touch with WHO as WHO actually provided the report based on the investigation which was done to prove that it was because of the diethylene glycol contamination. It is a very serious issue and it has to be taken very seriously," said Swaminathan. In India there are central as well as state-level drug regulators and there is a need to harmonize their operations, she said. "There are no mechanisms where regulators of different states can actually work together, do the inspections on each other's products," .

Cough syrup makers see healthy future, say controversies won't dent demand

Pharma industry insiders claimed that most contamination-related problems arise due to solvents

After the Gambia, Nigeria, Liberia issue alerts over Maiden Pharma's syrups

Nigeria has reportedly circulated the alert across all professional bodies, health care providers and supply chain associates

Several states initiate action over contaminated cough syrup controversy

According to the media reports, Karnataka has directed all drugmakers to test samples of glycerine and propylene glycol and submit a report within seven days.

Best of BS Opinion: Beyond inflation target, lessons from Maiden, and more

Here is the best of Business Standard's opinion pieces for today

EAM talks to Gambian counterpart on kids' death linked to cough syrups

Dr S. Jaishankar spoke to his Gambian counterpart Dr. Mamadou Tangara and conveyed condolences on the deaths of young children allegedly linked to the contaminated cough syrups produced in India